Physician profile
Steffi Sharma
NPI 1558884114
$4,554.81
in general payments reported to CMS, 2019-2025
9 companies · $1,417 in 2025
The $1,417 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.69 · 2021: $28.95 · 2023: $547 · 2024: $2,545 · 2025: $1,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,041 · Travel and Lodging: $1,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,040.54 |
| Travel and Lodging | $1,468.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,457.26 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Avita Medical Americas, LLC | $273.12 | 2023-2024 | Recell |
| Integra Lifesciences Corporation | $270.14 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Motiva USA, LLC | $236.30 | 2025 | |
| Baxter Healthcare | $145.38 | 2025 | Artiss |
| Heron Therapeutics, INC. | $99.64 | 2023 | Zynrelef |
| W. L. Gore & Associates, INC. | $28.95 | 2021 | |
| Stryker Corporation | $27.33 | 2023 | Na, Stryker Varispeed, Smartlock |
| Ethicon US, LLC | $16.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steffi Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.